German China

Microfluidic, Degassing Components Enhancing the Performance of SPR Instruments

Source: Press release Biotech Fluidics 1 min Reading Time

Biotech Fluidics is supplying key microfluidic and degassing components to Bionavis Oy for its range of Multi-Parametric Surface Plasmon Resonance (MP-SPR) instruments.

Fluidic valves and two degassing chambers installed in MP-SPR instrument. (Source:  Biotech Fluidics)
Fluidic valves and two degassing chambers installed in MP-SPR instrument.
(Source: Biotech Fluidics)

Surface Plasmon Resonance is the ‘go to’ technique for the measurement of molecular interactions in fluidics including serum, saliva, and organic solvents. SPR technology beneficially allows evaluation of affinity and kinetics of molecular binding reactions without the burdens of labelling as the technique is label-free. The Bionavis Navi range of advanced MP-SPR instruments provide superior features and performance enabling both studies of surface interactions as well as nanolayer characterization, shares the company.

Navi MP-SPR instruments are helping scientists with antibody characterization through drug uptake routes, controlled drug release strategies, small molecule measurements, nanoparticle targeting up to drug internalization by living cells.

Bionavis comments that the key part of the MP-SPR fluidics systems are Idex port selection valves supplied by Biotech Fluidics. These high-quality valves contribute to precise handling of samples, allowing researchers to control the timing, volume, and flow rate of injected liquids. This precision is vital for achieving reproducible results and minimizing variations in sample concentration. Additionally, the Degasser system supplied by Biotech Fluidics helps maintain sample integrity by preventing the introduction of air bubbles, which can disrupt measurements. Careful fluidic design and efficient degassing techniques eliminate bubbles and preserve the stability of the sample, ensuring reliable data, adds Bionavis.

(ID:50635276)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent